EUVIMEDEUVIMED entdecken
Crossref

First audiological results with the novel active bone conduction implant Sentio in SSD patients

Susan Busch, Nils Prenzler, Rolf Salcher, Kerstin Willenborg, Jasmin Thormählen, Thomas Giere, Thomas Lenarz

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S243-S244

DOI: 10.1055/s-0044-1784800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Susan Busch und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The active transcutaneous bone conduction implant system Sentio (Oticon Medical AB, Askim, Sweden) was developed to treat patients with conductive and mixed hearing loss, and single-sided deafness (SSD). The Sentio Ti implant is positioned under the skin behind the ear with the actuator placed in a bone bed and fixed on the mastoid with a fixation band and two screws. The external processor Sentio 1 is magnetically attached to the head. Currently, the Sentio is implanted as part of an international multicenter study (clinicaltrials.gov identifier NCT05166265). The aim of this report is to share preliminary audiological outcome and patient satisfaction for the Sentio system in the first SSD patients implanted at our clinic.

Method

Five patients between 25 and 58 years of age with SSD and a normal hearing contralateral ear (bone conduction PTA4 9.0±3.2 dB HL and air conduction PTA4 9.5±2.9 dB HL) were implanted with the Sentio TI between April and October 2023. Four of the five patients were already fitted with the Sentio 1 processor. A first analysis of clinical outcome data was based on unaided and aided sound field audiograms with the contralateral ear muffled and plugged and the word recognition scores (in%) in quiet using the German Freiburg monosyllable test.

Results

Average pure-tone thresholds improved substantially from 58.8±2.5 dB HL in unaided condition to 21.5±1.6 dB HL aided with the Sentio. The average word recognition in quiet of all five patients was 0% preoperative and 98.8% with the Sentio (n=4). The Sentio is well received by the patients and the subjective benefit and satisfaction is high.

Discussion

First results indicate an improvement in speech perception in quiet and satisfaction with the Sentio system in patients with SSD. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Busch, S., Prenzler, N., Salcher, R., Willenborg, K., Thormählen, J., Giere, T., & Lenarz, T. (2024). First audiological results with the novel active bone conduction implant Sentio in SSD patients. Laryngo-Rhino-Otologie, 103(S 02 S 02), S243-S244. https://doi.org/10.1055/s-0044-1784800

Vancouver

Busch S, Prenzler N, Salcher R, Willenborg K, Thormählen J, Giere T, et al. First audiological results with the novel active bone conduction implant Sentio in SSD patients. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S243-S244. doi:10.1055/s-0044-1784800

BibTeX
@article{Busch2024,
  author = {Busch, Susan and Prenzler, Nils and Salcher, Rolf and Willenborg, Kerstin and Thormählen, Jasmin and Giere, Thomas and Lenarz, Thomas},
  title = {First audiological results with the novel active bone conduction implant Sentio in SSD patients},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S243--S244},
  doi = {10.1055/s-0044-1784800}
}
Kostenlos starten →